The first study to measure the industry’s total emissions has found that the top 25 biopharma companies have reduced their carbon impact. The report — prepared by the non-profit organization My Green Lab, which promotes sustainability in science — was released to coincide with the United Nations COP28 Climate Summit in Dubai. The study identified critical hotspots that could open up opportunities for positive change. The evaluation, which included data from 226 public and 147 private companies, showed that the top 25 organizations by revenue have reduced some of their annual emissions — those from owned sources and purchased energy for in-house use — by around by 5.3% a year since 2015. And more than half of companies are now certified by My Green Lab, a best-practice standard that covers themes related to energy, water, waste, chemicals, materials, and engagement.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
209,00 € per year
only 17,42 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Log in
Learn about institutional subscriptions
Read our FAQs
Contact customer support
About this article
Cite this article
Top biopharmas’ zero-carbon drive.
Nat Biotechnol42, 6 (2024). https://doi.org/10.1038/s41587-023-02102-1
Download citation
Published: 17 January 2024
Issue Date: January 2024
DOI: https://doi.org/10.1038/s41587-023-02102-1
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Nature.com – https://www.nature.com/articles/s41587-023-02102-1
